The search for effective and safe disease control in psoriasis

The Lancet

Volumn 371, Issue 9621, 2008, Pages 1311-1312

  Naldi, Luigi ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; ISA 247; METHOTREXATE; PLACEBO; PSORALEN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE CONTROL; DISEASE SEVERITY; DOSE RESPONSE; DRUG SAFETY; HUMAN; LONG TERM CARE; LOW DRUG DOSE; NEPHROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; PSORIASIS VULGARIS; PUVA; RELAPSE; REMISSION; TREATMENT DURATION;

EID: 42049119603     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60571-1     Document Type: Note

References (12)

1. Updike J. From the journal of a leper. Problems and other stories (1980), Deutsch, London 181-197
2. Harper J., Keat A., and Staughton R. Cyclosporin for psoriasis. Lancet 2 (1984) 981-982
3. Papp K., Bissonette R., Rosoph L., et al. Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study. Lancet 371 (2008) 1337-1342
4. Katz K. "Biologics": a clinically meaningless term. Br J Dermatol 154 (2006) 809-812
5. van de Kerkhof P., de Hoop D., de Korte J., Cobelens S., and Kuipers M. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 200 (2000) 292-298
6. Naldi L., Svensson A., Diepgen T., et al., for the European Dermato-Epidemiology Network. Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. J Invest Dermatol 120 (2003) 738-741
7. Liptak P., and Ivanyi B. Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2 (2006) 398-404
8. Marcil I., and Stern R. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet 358 (2001) 1042-1045
9. Paul C., Ho V., McGeown C., et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 120 (2003) 211-216
10. Huerta C., Rivero E., and Rodríguez L. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 143 (2007) 1559-1565
11. Setty A., Curhan G., and Choi H. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 167 (2007) 1670-1675
12. Remuzzi G., Schieppati A., Boissel J., Garattini S., and Horton R. Independent clinical research in Europe. Lancet 364 (2004) 1723-1726